Company Fundamentals\Company Profile
A Wright Investors' Service Research Report:
China Pharmaceutical Group Limited
440 Wheelers Farms Road
Milford, CT 06461 U.S.A.
COMPANY PROFILE
Figures in Hong Kong Dollars
Wright Quality Rating:CAB18 Key Data
China Pharmaceutical Group Limited is an investment holding company. The Company Ticker:
and its subsidiaries are principally engaged in the manufacture and sale of 1093
pharmaceutical products. The Company is operating in three business segments:
manufacture and sale of intermediate and bulk drugs including vitamin C series and 2010 Sales:
antibiotics series (i.e. penicillin series and cephalosporin series); finished drugs, and
7,774,424,000
other pharmaceutical related businesses. During the year ended December 31, 2010,
the Company enhanced its scale of operation through extension of its product chain.
In addition to its core products of 7-ACA and cefazolin sodium, its cephalosporin Major Industry:
series of products had extended to GCLE, ceftriaxone sodium, cefuroxime sodium, Drugs, Cosmetics & Health
cefuroxime acid, cefotaxime sodium, cefotaxime acid and cefixime. The production Care
facilities of China Pharmaceutical Group Limited are located in Shijiazhuang City,
Hebei Province and Hohhot, Inner Mongolia, China. Sub Industry:
Stock Chart Officers Ethical Drug Manufacturers
Chairman & Chief Executive
Dongchen Cai Country:
Hong Kong
Secretary
Ka Sze Lee Currency:
Hong Kong Dollars
Fiscal Year Ends:
December
Employees
10,687
Exchanges:
HKG
Share Type:
Ordinary
Stock Price (8/12/2011): 3.21
Recent stock performance
1 Week -4.5% Market Capitalizati